Pharmacists in Johnsonville, SC Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Dr. April E Newell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 239 Stuckey St, Johnsonville, SC 29555 Phone: 843-386-6135 |
Dawn Mcelveen Munn, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 123 E Broadway St, Johnsonville, SC 29555 Phone: 843-438-0178 Fax: 843-438-0179 |
 Mr. Derrick Allan Wall, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 239 Stuckey St, Johnsonville, SC 29555 Phone: 843-386-6135 Fax: 843-380-1025 |
Dr. Chandace B Tanner, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 538 Myrtle Wood Ln, Johnsonville, SC 29555 Phone: 843-386-9080 |
News Archive
New study examines best practices in teaching medical students to better detect skin lesions
Each year, thousands of Canadians are given the news: they have skin cancer. It is the most common form of cancer in Canada and around the world, but if detected early, survival rates are extremely high. According to Liam Rourke, it doesn't happen nearly as often as it could.
FDA panel recommends approval of CryoCor's device for treatment of atrial flutter
CryoCor, Inc. has announced that the Advisory Panel of the United States Food and Drug Administration, or FDA, recommended that CryoCor's application for pre-market approval, or PMA, for the treatment of atrial flutter be approved by the FDA.
Newly discovered nerve cells trigger locomotion, supply the brain with speed-related information
Scientists at the German Center for Neurodegenerative Diseases and the University of Bonn led by Prof. Stefan Remy report on this in the journal "Neuron". Their investigations give new insights into the workings of spatial memory. Furthermore, they could also help improve our understanding of movement related symptoms associated with Parkinson's disease.
New insights into cancer-induced intussusceptive angiogenesis
Researchers have gained a new understanding of the way in which growing tumors are fed and how this growth can be slowed via angiogenesis inhibitors that eliminate the blood supply to tumors. This represents a step forward towards developing new anti-cancer drug therapies.
Atopix awarded grant to pursue development of OC459 for atopic dermatitis
Atopix Therapeutics Ltd, a biopharmaceutical company developing a novel class of anti-allergic medicines, has been awarded a £1.7 million grant from the UK Biomedical Catalyst fund to pursue development of OC459 in the treatment of moderate-to-severe atopic dermatitis (a form of eczema).
› Verified 7 days ago